Light therapy topical systems to augment outcome
Patented and patent pending topical systems to be combined with human and animal light therapies. The plant-based lipophilic high refractive index topicals partition within the stratum corneum creating a refractive index matched matrix that significantly reduces skin surface and skin sub-surface light scatter, reduces skin surface light trapping, light confinement and skin surface heating regardless of skin tone.
The system is in current use with >15,000 Class-4 laser musculoskeletal treatments since November 2023. 100s added weekly. Notably, the topical system allows for effective laser therapy on tattooed skin areas, a prior resistive situation.
45 patients have received a recently developed aesthetics topical system combining skin bioactives with light therapy. The combined bioactive topicals with the lipophilic topical provides a synergistic and rapid skin firming/ reduction in lines/ wrinkles.
About LUCI Therapeutics
LUCI Therapeutics is a biotechnology and materials science company specializing in high-refractive-index topicals designed to optimize light and laser therapies. The company’s patented and patent-pending technology works by optically clearing the stratum corneum, which reduces light scatter and enables deeper penetration of light into tissues. This approach is engineered to enhance the efficacy of photobiomodulation, laser, and IPL treatments across a wide range of applications, including skincare, musculoskeletal pain management, body contouring, and aesthetic procedures. By temporarily matching the refractive index of the skin, the products help ensure consistent delivery of light energy for patients of all skin tones, including those with tattoos.
The company's innovations provide significant utility for professional clinicians and at-home users seeking more effective light-based therapeutic outcomes. By clearing the skin surface to minimize energy loss, LUCI Therapeutics’ formulas aim to improve results for procedures such as hair removal, scalp care, and ocular health. The technology has been validated through collaborative development with industry partners in the laser and light-therapy sectors, as evidenced by its integration into professional treatment lines. LUCI Therapeutics continues to advance the science of light-tissue interaction, focusing on improving the safety and dosing efficiency of light therapies.
delivered to your inbox.